Mural Oncology PLC - Multiplikator EV/Sales MURA

Mural Bio (MURA) - logo korporat

Compliance with environmental regulations and the filtration of emissions at Mural Oncology plc (MURA) laboratories impact capital expenditures. The current enterprise value-to-revenue valuation visualizes these expenses, where 0.00 indicates the current level. Optimization is possible by establishing a closed patent perimeter for cytokine therapy and overcoming strict FDA barriers, which will protect R&D investments from competition.

Mural Oncology (MURA) - Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.12.2025

MURA (Mural Oncology PLC): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:Mural Oncology plc
Barang utama Mural Oncology

The integration of robotic systems and AI into the molecular design of Mural Oncology plc (MURA) radically accelerates R&D, creating high added value. The EV-to-revenue trend allows for the filtering of market noise by assessing the enterprise value relative to revenue generation, which serves as an objective indicator of actual capital flows and the fundamental revaluation of the company by investors.

Analisis pesaing

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales HURA (TuHURA Biosciences, Inc.)|Nilai bisnis marang pendapatan TARA|FATE: Nilai perusahaan marang pendapatan|WHWK (aadibio.com) - Rasio nilai perusahaan marang pendapatan|TCRX (TScan Therapeutics, Inc.) - Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Multiplikator EV/Sales|CVM (CEL-SCI Corporation) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSTX|Multiplikator EV/Sales Radiopharm Theranostics Ltd (RADX)|Multiplikator EV/Sales ARTV (Artiva Biotherapeutics)|Multiplikator EV/Sales Adlai Nortye Ltd. ANL|Veru Inc - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Tempest Therapeutics TPST|XLO: Multiplikator EV/Sales|Enochian BioSciences (RENB) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan